Lipid Management Connect
Profile Image
  • Saved
Sustained Type 2 Diabetes Remission and Metabolic Health Through Intensive Lifestyle Intervention: A Case Report With a Nine-Year Follow-Up. - PubMed

Sustained Type 2 Diabetes Remission and Metabolic Health Through Intensive Lifestyle Intervention: A Case Report With a Nine-Year Follow-Up. - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/42460222

A whole-food, plant-based diet, exercise, and stress reduction contributed to a nine-year type 2 diabetes remission, highlighting potential cardiovascular benefits.


Intensive lifestyle intervention led to sustained type 2 diabetes remission and metabolic health improvement over nine years without medications, with potential cardiovascular benefits.

Profile Image
  • Saved
Ferroptosis in Doxorubicin-Induced Cardiotoxicity: From Molecular Mechanisms to Therapeutic Strategies and Clinical Management Paradigms. - PubMed

Ferroptosis in Doxorubicin-Induced Cardiotoxicity: From Molecular Mechanisms to Therapeutic Strategies and Clinical Management Paradigms. - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/42416573

Explore the role of ferroptosis in doxorubicin-induced cardiotoxicity and review potential therapeutic strategies targeting this pathway for cardiac management.


Ferroptosis is central in doxorubicin-induced cardiotoxicity, involving disrupted iron homeostasis and lipid peroxidation. Strategies include inhibiting GPX4, FSP1, and using cardiac-targeted nanodelivery systems.

Profile Image
  • Saved
Inclisiran Response in a Patient With Familial Hypercholesterolemia After Suboptimal Response to Evolocumab. - PubMed

Inclisiran Response in a Patient With Familial Hypercholesterolemia After Suboptimal Response to Evolocumab. - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/42397340

A patient with familial hypercholesterolemia responded well to inclisiran after an inadequate response to evolocumab, as detailed in this case report.


Inclisiran showed efficacy in reducing LDL cholesterol in a patient with familial hypercholesterolemia (Afrikaner-2 variant) after suboptimal response to evolocumab.

Profile Image
  • Saved
Biologics for cardiovascular diseases: from bench to bedside. - PubMed

Biologics for cardiovascular diseases: from bench to bedside. - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/42366210

Explore the role of biologics, including gene therapies and lipid modulation, in managing cardiovascular diseases by addressing pathophysiological mechanisms.


Biologics offer potential for disease modification in cardiovascular medicine, focusing on cardiac regeneration, reverse remodeling, genetic correction, vascular modulation, and lipid metabolism.

Profile Image
  • Saved
National Heart Center/Saudi Heart Association 2025 Guidelines for Cardiovascular Diseases Prevention and Risk Assessment. - PubMed

National Heart Center/Saudi Heart Association 2025 Guidelines for Cardiovascular Diseases Prevention and Risk Assessment. - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/41628971

Explore the 2025 guidelines for cardiovascular disease prevention in Saudi Arabia, highlighting primary risk assessment and secondary comorbidity management.


The 2025 guidelines emphasize tailored prevention strategies for cardiovascular diseases in Saudi Arabia, focusing on primary prevention through risk assessment and secondary prevention with comorbidity management.

Profile Image